Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Hematopoietic stem cell transplantation outcomes improved for severe combined immunodeficiencies (SCIDs) and other primary immunodeficiencies (non-SCID PIDs) between 1968-2005. Donor type significantly impacts survival, with genoidentical and phenoidentical donors offering better prognoses.
Area Of Science
- Immunology
- Hematology
- Transplantation Science
Background
- Hematopoietic stem cell transplantation (HSCT) is the primary treatment for severe combined immunodeficiencies (SCIDs) and other primary immunodeficiencies (non-SCID PIDs).
- Long-term outcomes for HSCT in these patient populations have not been extensively analyzed across diverse European centers.
- Understanding survival trends and prognostic factors is crucial for optimizing patient care.
Observation
- This study analyzed long-term HSCT outcomes in SCID and non-SCID PID patients from European centers (1968-2005).
- Survival rates for SCID patients using genoidentical donors (90%) and unrelated donors (69%) showed improvement over time.
- For non-SCID PID, unrelated donor transplants (79%) demonstrated survival rates similar to genoidentical donors (79%) in the 2000-2005 period.
Findings
- Transplantation post-1995, younger age, specific donor types (genoidentical, phenoidentical), and absence of pre-transplant complications improved SCID patient survival.
- Mismatched related donors were associated with poorer outcomes in both SCID and non-SCID PID groups.
- While survival has improved for SCID, non-SCID PID survival remains lower, despite a broader range of treated conditions.
Implications
- These findings highlight the importance of donor selection and pre-transplant condition in HSCT success.
- Further analysis of individual disease categories within non-SCID PIDs is needed for tailored treatment strategies.
- Optimizing HSCT protocols based on specific immunodeficiency types can enhance long-term patient survival and quality of life.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
A body temperature above 38°C (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Suppose a bacterial infection is the cause of fever. In that case, the healthcare provider obtains culture specimens...
Hyperthermia occurs when the body's temperature becomes unusually high, often due to heat exposure, intense physical activity, or certain illnesses. This condition can create a dangerous cycle where elevated body temperature increases the metabolic rate, generating more heat and potentially leading to organ failure and brain damage. A severe form of hyperthermia, called heat stroke, can raise body temperature to life-threatening levels. Fever, on the other hand, is a controlled form of...